1 / 38

Urologic Tuberculosis Xu Ha Department of Urology, Tongji Hospital

Urologic Tuberculosis Xu Ha Department of Urology, Tongji Hospital. Tuberculosis (TB). Pathogen — Mycobacterium tuberculosis Infected — one third of world's population Organism — lung first, through bloodstream to other Probability — exposure, size, and infectivity

Download Presentation

Urologic Tuberculosis Xu Ha Department of Urology, Tongji Hospital

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Urologic Tuberculosis Xu Ha Department of Urology, Tongji Hospital

  2. Tuberculosis (TB) • Pathogen— Mycobacterium tuberculosis • Infected — one third of world's population • Organism — lung first, through bloodstream to other • Probability — exposure, size, and infectivity • Initial infection — most controlled and no clinical illness • Clinical disease — multiplication of dormant bacilli

  3. Genitourinary TB • Account for 10% of tuberculosis cases • Most 20 to 40 years old • Male VS female — 2:1 • Very uncommon in children • Spread of organism to kidney through blood • Other parts become involved by direct extension

  4. Pathologic Features Kidney • Caseating granuloma • Caseous abscess • Fibrosis • Calcification • Papillary necrosis • Calyceal stem or UPJ obstruction • Autonephrectomy Caseating granuloma

  5. Fibrosis

  6. Caseous abscess, Fibrosis and Calcification

  7. Pathologic Features Ureter • Mucosa or submucosa tubercular nodule • Stricture formation • Granuloma • Fibrosis Ureter with calcification and stricture formation

  8. Pathologic Features Bladder • Ureteral orifice inflamed and edematous • Ureteral orifice obstruction • Tuberculous ulcers • Tuberculous inflammation • Bladder wall fibrosis and contraction

  9. Acutely inflamed ureteric orifice Tuberculous bullous granulations

  10. Tuberculous golf-hole ureter severely withdrawn Acute tuberculous ulcer

  11. Acute tuberculous cystitis with ulceration Healed tuberculous lesion

  12. Clinical Manifestations The diagnosis of genitourinary TB should be considered in a patient presenting with vague, longstanding urinary symptoms for which there is no obvious cause!

  13. Clinical Manifestations SPECIFIC - Genitourinary tract Lower urinary tract – 50 to 80 % • Burning , frequency , urgency , urge incontinence • Dysuria , hematuria • Suprapubic pain / perineal discomfort • Decreased stream , straining, ineffective voiding • Slough in urine

  14. Clinical Manifestations Genital – Female • Menstrual irregularities • Pelvic pain syndrome • Infertility – 18 % Upper urinary tract symptoms • Pain - kidney and ureter region • Gross hematuria- 10 % Genital – Male • Hematospermia - 10 % • Azoospermia • S/S of chronic epididymorchitis

  15. Clinical Manifestations Other systems • Respiratory - 12 % patients • Gastrointestinal - 10 % • Lymphoreticular Constitutional - 10 to 15 % • Evening rise of temperature • Weight loss • Anorexia

  16. Diagnosis Laboratory Urinalysis and Culture • Acidic urine , sterile pyuria , microscopic hematuria • Guide for further investigation, especially in pauci-symptomatic patients • Fastidious / slow growth – difficult to culture – at least three, but preferably five

  17. Diagnosis Laboratory Purified Protein Derivative (PPD, Tuberculin Test, Mantoux Test) • If Positive – supports the diagnosis • If Negative – can not exclude extrapulmonary TB • Response – HIV, Immunocompromised , Post-transplant pts

  18. Diagnosis Laboratory Nucleic Acid Amplification (NAA) Testing—PCR • Multiple sample • Sensitivity from 87% to 95% (VS culture) • Specificity from 92% to 99.8% (VS culture) • Resistance mutations

  19. Diagnosis Radiography • Plain Radiograph • Positive findings up to 50% on chest radiograph • Calcifications in 30% to 50% case on KUB

  20. Diagnosis Radiography • Intravenous Urography (IVU) • Traditional gold standard tool • Replaced by CT in many institutions • Early signs: calyceal erosion and papillary irregularity • Most common: hydrocalycosis, hydronephrosis, orhydroureter

  21. Diagnosis Radiography • Intravenous Urography (IVU)— kidney • Calyx distortion • Calyx fibration • Calyx occlusion • Calyceal destruction • Parenchymal destruction

  22. Diagnosis Radiography • Intravenous Urography (IVU)— ureter • Dilatation above UVJ stricture • Rigid fibration • Multiple strictures

  23. Diagnosis Radiography • Intravenous Urography (IVU)— bladder • Small and contracted (thimble bladder) • Irregular with filling defects • Asymmetry

  24. Occluded calyx Severe calyceal and  parenchymal destruction

  25. Stricture at the distal left ureter Contraction of the bladder left side

  26. Diagnosis Radiography • Computed Tomography (CT) • Three-dimensional reconstructed images • At least the equal of IVU in identification • Findings with not specific

  27. Computed Tomography (CT) • Calyceal abnormalities • Hydronephrosis or hydroureter • Autonephrectomy • Amputated infundibulum • Urinary tract calcifications • Renal parenchymal cavities Hydronephrotic in right kidney End-stage nonfunctioning atrophic left kidney with calcification.

  28. Diagnosis Endoscopy • Cystoscopy and Biopsy • Rarely indicated in diagnosis • Must under general anesthesia • Assessing the disease extentor the response to chemotherapy • No Biopsy advised before medical therapy

  29. Treatment • Successful treatment • Early diagnosis • Prompt initiation of adequate drug • Rest and nutrition • Urgical treatment for advanced cases

  30. Treatment Medical Treatment • Multidrug treatment • Initial 6-month regimens of rifampicin, INH, pyrazinamide, and ethambutol • Administered in one dose • Dosage, toxicity, drug interactions

  31. Treatment Antituberculous Drugs

  32. Treatment Antituberculous Drugs

  33. Treatment Surgical Therapy • Adjuvant to medical therapy • Focus on organ preservation and reconstruction • At least 4 to 6 weeks medical therapy before • Excision of diseased tissue and reconstructive

  34. Treatment Surgical Therapy Excision of diseased • Nephrectomy • Partial Nephrectomy • Abscess Drainage

  35. Treatment Surgical Therapy Indications for nephrectomy • A nonfunctioning kidney with or without calcification • Extensive disease involving the whole kidney, together with hypertension and UPJ obstruction • Coexisting renal carcinoma

  36. Treatment Surgical Therapy Reconstructive Surgery • Ureteral strictures • Augmentation cystoplasty • Urinary conduit diversion • Orthotopic neobladder

  37. Summary • Part of general tuberculosis caused by Mycobacterium tuberculosis • Vague, longstanding urinary symptoms with no obvious cause • Urinalysis and culture and radiography for diagnosis • Basilic medical treatment • Adjuvant surgical therapy

  38. THANK YOU

More Related